Gerresheimer, DE000A0LD6E6

Gerresheimer completes Centor sale: Gerresheimer stock gains 2.40 percent

Published on 10/06/2026 at 12:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Adjusted EBITDA rose to EUR 102.00 million in Q2 2026 from EUR 67.00 million. Gerresheimer stock costs EUR 29.00 on October 6, 2026 after EUR 28.32.

Editorialfoto eines Trading-Floors mit MDAX- und Xetra-Kurstafeln
Gerresheimer AG, ISIN DE000A0LD6E6, notiert im MDAX an der Frankfurter Börse Xetra, Trading-Floor-Editorialbild, Illustration mit AI erstellt.

Gerresheimer (ISIN DE000A0LD6E6) was trading at EUR 29.00 at Lang & Schwarz on October 6, 2026 at 12:51 p.m. CEST, up 2.40 percent versus the prior close of EUR 28.32. On October 1, 2026, EQS Group reported that Gerresheimer completed the sale of its US subsidiary Centor, with proceeds intended to reduce debt.

Centor sale reduces debt pressure

The completed transaction is part of a broader portfolio reshaping plan. Gerresheimer said the combined enterprise value of Centor and its Primary Packaging Plastics business is EUR 1.50 billion, with the PPP transaction expected to close in the first half of 2027, according to EQS Group on October 1, 2026.

The debt issue remains material for the equity story. Investing.com reported that net financial debt remained above EUR 2.00 billion in the second quarter of 2026, while free cash flow before mergers and acquisitions was negative EUR 92.00 million.

Quarterly recovery meets balance-sheet risk

Gerresheimer's preliminary second-quarter 2026 revenue reached EUR 578.00 million, up from EUR 523.00 million in the first quarter but down from EUR 614.00 million in the second quarter of 2025. Adjusted EBITDA increased from EUR 67.00 million to EUR 102.00 million, a 52.24 percent quarter-over-quarter improvement, according to FT.com on September 30, 2026.

The comparison is uneven but informative: operational earnings improved 52.24 percent sequentially, while revenue remained 5.86 percent below the prior-year quarter. That gap leaves execution, utilization and debt reduction as the central tests for the second half of 2026.

Jefferies keeps a cautious valuation

dpa-AFX reported on September 30, 2026 that Jefferies kept its Hold rating and EUR 26.80 price target after the preliminary quarterly figures. The analyst cited the improved result versus the first quarter but also pointed to higher net debt and lower liquidity.

Stock trades below yearly high

Gerresheimer stock was trading at EUR 29.00 at Lang & Schwarz on October 6, 2026 at 12:51 p.m. CEST, versus the EUR 28.32 prior close. The same-day 52-week range was EUR 14.83 to EUR 38.28, placing the quote EUR 9.28 below the high, while market capitalization stood at EUR 996.8 million.

The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.

Gerresheimer stock facts

  • Company: Gerresheimer AG
  • ISIN: DE000A0LD6E6
  • WKN: A0LD6E
  • Ticker: GXI
  • Primary exchange: Frankfurt Stock Exchange
  • Price Lang & Schwarz (as of October 6, 2026, 12:51 p.m. CEST): EUR 29.00
  • Change versus prior close: plus 2.40 percent
  • Prior close Lang & Schwarz (October 5, 2026): EUR 28.32
  • Market capitalization: EUR 996.8 million (as of October 6, 2026)
  • 52-week range: EUR 14.83-EUR 38.28 (as of October 6, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

More news and analyses on Gerresheimer stock

Disclaimer...

en | DE000A0LD6E6 | GERRESHEIMER | boerse | 70241616 | bgmi